RFP
KYMR icon

Root Financial Partners’s Kymera Therapeutics KYMR Stock Holding History

Root Financial Partners’s Portfolio KYMR Stock Details KYMR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$6.66K Sell
80
-4
-5% -$317 ﹤0.01% 1837
2025
Q4 		$6.54K Buy
84
+44
+110% +$2.97K ﹤0.01% 1673
2025
Q3 		$2.26K Buy
+40
New +$1.8K ﹤0.01% 1936

Other funds holding KYMR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return

Root Financial Partners's KYMR Position: Q1 2026 in Review

Root Financial Partners reduced its Kymera Therapeutics (KYMR) stake by 4.8% in Q1 2026, selling an estimated $317 and leaving 80 shares worth $6.66K. The position accounts for ﹤0.01% of the portfolio, ranked #1837.

Root Financial Partners first reported a position in KYMR in Q3 2025 and has held it in 3 quarters since. 256 funds tracked by Wall St. Rank hold KYMR as of Q1 2026.

  • Root Financial Partners held 80 shares of Kymera Therapeutics worth $6.66K as of Q1 2026.
  • Root Financial Partners sold 4 Kymera Therapeutics shares in Q1 2026, an estimated $317.
  • Kymera Therapeutics made up ﹤0.01% of Root Financial Partners's portfolio in Q1 2026, its #1837 holding.
  • Root Financial Partners first reported a position in Kymera Therapeutics in Q3 2025 and has held it in 3 quarters since.
  • 256 funds tracked by Wall St. Rank held Kymera Therapeutics as of Q1 2026.

Based on Root Financial Partners's 13F filing for Q1 2026, filed 24 Apr 2026.